BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2627674)

  • 1. Types and amounts of carcinogens as potential human cancer hazards.
    Weisburger JH; Williams GM
    Cell Biol Toxicol; 1989 Dec; 5(4):377-91. PubMed ID: 2627674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
    Parfett CL; Desaulniers D
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical carcinogen mechanisms of action and implications for testing methodology.
    Williams GM; Iatropoulos MJ; Weisburger JH
    Exp Toxicol Pathol; 1996 Feb; 48(2-3):101-11. PubMed ID: 8672863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is current risk assessment of non-genotoxic carcinogens protective?
    Braakhuis HM; Slob W; Olthof ED; Wolterink G; Zwart EP; Gremmer ER; Rorije E; van Benthem J; Woutersen R; van der Laan JW; Luijten M
    Crit Rev Toxicol; 2018 Jul; 48(6):500-511. PubMed ID: 29745287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.
    Melnick RL; Kohn MC; Portier CJ
    Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):123-34. PubMed ID: 8722116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern criteria to determine the etiology of human carcinogens.
    Mossman BT; Klein G; Zur Hausen H
    Semin Cancer Biol; 2004 Dec; 14(6):449-52. PubMed ID: 15489138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
    Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
    Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of multiple mechanisms of carcinogenesis for short-term testing.
    Harper BL; Morris DL
    Teratog Carcinog Mutagen; 1984; 4(6):483-503. PubMed ID: 6151260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-stage models of carcinogenesis, classification of agents, and design of experiments.
    Portier CJ; Edler L
    Fundam Appl Toxicol; 1990 Apr; 14(3):444-60. PubMed ID: 2340975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of human carcinogens.
    Barrett JC; Shelby MD
    Prog Clin Biol Res; 1992; 374():415-34. PubMed ID: 1620716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
    Slamenová D
    Neoplasma; 2001; 48(6):425-34. PubMed ID: 11949832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis.
    van Leeuwen IM; Zonneveld C
    Mutat Res; 2001 Oct; 489(1):17-45. PubMed ID: 11673088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
    Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
    Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.